US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Apr 22, 2025 (17 months ago)

Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.

What was recalled

Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02

Recalling firm
RemedyRePack Inc.
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0411-2025

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Clindamycin recalls

See all